San Francisco Reaches $58M Opioid Settlement with Teva, Allergan
Teva Pharmaceutical Industries and AbbVie's Allergan unit on Tuesday reached a $58 million settlement with the city of San Francisco just before
Source: claimsjournal.com
Stay updated with breaking news from Kare Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teva Pharmaceutical Industries and AbbVie's Allergan unit on Tuesday reached a $58 million settlement with the city of San Francisco just before
Teva will pay $25m in cash and contribute a $20m supply of an overdose-reversal drug; AbbVie’s Allergan will pay $13m.
These highly profitable stocks are valued at just three to six times Wall Street's forecast earnings for 2023.
With the broader market tumbling, value stocks are bound to come into focus.
Two drugmakers have been in mediation talks with plaintiffs for more than a year